Skip to main content
. 2017 Dec 13;9(87):35780–35789. doi: 10.18632/oncotarget.23200

Table 4. Comparison of drug resistance between ESBL positive and negative bacteria.

Antibiotics ESBL (+) ESBL (–) P value
Total number Resistant rate (n, %) Total number Resistant rate (n, %)
Cefoperazone 83 48 (57.83) 44 4 (9.10) 0.000
Cefperazone-Sulbactam 84 2 (2.38) 66 0 (0.00) 0.207
Ceftriaxone 107 107 (100.00) 82 7 (8.54) 0.000
Cefmetazon 88 3 (3.40) 70 0 (0.00) 0.119
Cefepime 107 58 (54.20) 82 5 (6.10) 0.000
Cefotaxime 25 24 (96.00) 15 0 (0.00) 0.000
Ceftazidime 108 72 (66.67) 84 7 (8.33) 0.000
Levofloxacin 107 66 (61.68) 83 22 (26.51) 0.000
Gatifloxacin 24 17 (70.83) 15 5 (33.33) 0.022
Imipenem 109 2 (1.83) 83 0 (0.00) 0.215
Meropenem 103 1 (0.97) 81 0 (0.00) 0.374
Amikacin 108 3 (2.78) 81 1 (1.23) 0.466
Piperacillin 60 58 (96.67) 52 26 (50.00) 0.000
Minocycline 26 9 (34.61) 16 2 (12.50) 0.113
SMZCO 109 88 (80.73) 82 47 (57.32) 0.000
Aztreonam 107 72 (67.29) 82 4 (4.88) 0.000
Fosfomycin 68 9 (13.23) 54 1 (1.85) 0.023
Furadantin 84 9 (10.71) 66 1 (1.51) 0.025
Ticarcillin/Clavulanate Potassium 93 50 (53.76) 69 24 (34.78) 0.016
Piperacillin/tazobactam 107 7 (6.54) 84 1 (1.19) 0.067
Ampicillin 106 103 (97.17) 78 53 (67.95) 0.000